# Progress Note 02 — Focused Visit (Intermediate follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Richard Roundtree (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML015-SYN-TD
- Date: 1993-10-05
- Fictional facility: St. Posthumous Health Center
- Fictional author: Leon Carrington, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Intermediate follow-up)

## Chief complaint

Biopsy results for a left breast lump. **S**

## History of present illness

Mr. Roundtree returns six days after first coming in with a painless lump under the left nipple. Diagnostic mammography and ultrasound of both breasts and both axillae the next day showed a 1.6 cm irregular mass eccentric to the left nipple and one abnormal left axillary lymph node; the right breast and axilla were normal. Core biopsies of the mass and the node the same day show invasive ductal carcinoma, grade 3, estrogen receptor 95 percent, progesterone receptor 85 percent, HER2 negative, with cancer in the node. He was asked to come in so the result could be given in person. He says he had not thought a man could get breast cancer and had been sure it was the breast enlargement he had at 13. He has no bone pain, cough, headache, abdominal pain, or weight loss. He saw Dr. Siddiqui of breast surgical oncology this morning, and the operation is booked in two days. His main worries are the operation, whether he can keep working, and keeping the diagnosis private. **S**

| Element | Detail |
|---|---|
| Diagnosis | Invasive ductal carcinoma, left breast, grade 3, ER and PR positive, HER2 negative; left axillary node positive |
| Other breast and axilla | Normal on mammography and ultrasound |
| Symptoms of spread | None |
| Coordination | Surgical oncology seen today; operation in two days |
| Concerns | The operation, work, and privacy |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No weight loss, fever, or night sweats |
| Respiratory | Negative | No cough or breathlessness |
| Musculoskeletal | Negative | No bone pain |
| Neurological | Negative | No headache or weakness |
| Gastrointestinal | Negative | No abdominal pain |
| Psychiatric | Positive | Worried and shaken; sleeping less; PHQ-9 score 5; no thoughts of self-harm |

6 systems reviewed. **S**

## Current medications

- No current medications. **S**

## Allergies

- No known allergy **S**

## Objective

BP 134/82 mmHg; pulse 82 bpm; respirations 16/min; temperature 36.8 °C; oxygen saturation 99% on room air; weight 85.6 kg; BMI 24.2 kg/m². All vital signs are synthetic.

Hemoglobin: 14.8 g/dL; White cell count: 6.6 10*3/uL; Absolute neutrophil count: 3.9 10*3/uL; Platelets: 246 10*3/uL; Sodium: 139 mmol/L; Potassium: 4.1 mmol/L; Creatinine: 1.02 mg/dL; eGFR: 89 mL/min/1.73 m²; Glucose: 92 mg/dL; Calcium: 9.5 mg/dL; ALT: 24 U/L; AST: 22 U/L; Alkaline phosphatase: 71 U/L; Total bilirubin: 0.7 mg/dL; Albumin: 4.4 g/dL; PHQ-9: 5. All results are synthetic.

## Physical examination

| System | Finding |
|---|---|
| General | Well; anxious but composed |
| Breasts | Left: 1.5 cm firm, irregular, painless mass eccentric to the nipple at 2 o'clock, not fixed to the chest wall; mild bruising from the biopsy; no nipple retraction or discharge. Right: no mass and no glandular enlargement |
| Lymph nodes | One firm, mobile 1 cm left axillary node; no right axillary, supraclavicular, or cervical nodes |
| Abdomen | Soft; liver not enlarged |
| Musculoskeletal | No spinal tenderness |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Invasive ductal carcinoma of the left male breast, clinical stage IIA (cT1c cN1 M0), ER and PR positive, HER2 negative** (C50.122). Breast cancer in a man, confirmed by biopsy. About 1 in 100 breast cancers occurs in a man, and a new firm, eccentric lump in a man needs this work-up whatever his earlier history. The other breast and axilla are normal. With no symptoms of spread and normal blood count, calcium, and liver tests, staging scans are not needed at this stage. **S**
   - Operation in two days with Dr. Siddiqui, as she advised.
   - Germline multigene panel sent today, with genetic counseling.
   - Medical oncology after the surgical pathology.
2. **Estrogen receptor-positive status** (Z17.0). Strongly hormone receptor-positive, so endocrine therapy will be part of his treatment; tamoxifen is the first choice for men. **S**
   - Endocrine therapy to be planned by medical oncology after surgery and any chemotherapy.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Imaging | Diagnostic mammography and ultrasound of both breasts and both axillae | At diagnosis | Up to date | Done the day after the first visit: left mass BI-RADS 5 with one abnormal node; right breast and axilla normal |
| Laboratory | Core biopsy with ER, PR, and HER2 status | At diagnosis | Up to date | Invasive ductal carcinoma, grade 3, ER 95 percent, PR 85 percent, HER2 1+ (negative), Ki-67 30 percent; node positive |
| Laboratory | Preoperative blood count and chemistry | Before surgery | Completed today | All normal: hemoglobin 14.8 g/dL, platelets 246, creatinine 1.02 mg/dL, eGFR 89, calcium 9.5 mg/dL, ALT 24 and alkaline phosphatase 71 U/L |
| Imaging | Staging CT, bone scan, or PET | Only for clinical stage III or symptoms or abnormal results suggesting spread | Not indicated | Clinical stage IIA with no symptoms and normal calcium, alkaline phosphatase, and liver tests |
| Laboratory | Germline multigene panel testing | Once, for every man with breast cancer | Ordered | Sent today; the result is not needed before surgery |
| Referral | Breast surgical oncology | At diagnosis | Completed today | Seen this morning; recommendations in the consultation note |
| Examination | Baseline arm circumference before axillary surgery | Once, before axillary surgery | Deferred | Not measured today, a deviation from the protocol; the visit was taken up with the diagnosis and the plan. To be addressed after surgery |
| Survey | Distress and depression screen (PHQ-9) | At diagnosis and each visit | Completed today | PHQ-9 score 5, mild, with worry about the operation and work; no thoughts of self-harm |
| Self-management | Information and support | At diagnosis | Completed today | Told plainly that men get breast cancer and that it is treated as well in men as in women; written information for men with breast cancer and details of a peer-support group given; confidential handling of his records and a work note offered |

## Goal progress

- Tissue diagnosis within one week of presentation. Outcome by 1993-10-05: Imaging and core biopsy the day after presentation; diagnosis explained on the sixth day. **S**
- Curative surgery within two weeks of diagnosis, with lymphedema prevention taught. In progress; target 1993-10-20. **S**
- Complete germline genetic testing with counseling before chemotherapy starts. In progress; target 1993-10-27. **S**
- Be ready to start adjuvant chemotherapy within six weeks of surgery: echocardiogram, hepatitis B screening, vaccines, and dental review done. In progress; target 1993-10-27. **S**

## Guideline basis

- Hassett MJ, et al. Management of Male Breast Cancer: ASCO Guideline. J Clin Oncol 2020;38(16):1849-1863 (2020), American Society of Clinical Oncology
- NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 5.2025 (2025), National Comprehensive Cancer Network
- Bedrosian I, et al. Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline. J Clin Oncol 2024;42(5):584-604 (2024), American Society of Clinical Oncology and Society of Surgical Oncology
- CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026), Aether Forge

## Follow-up

- Surgery in two days. Primary care review about two weeks after surgery, after the pathology. Medical oncology after the pathology. Call the surgical team for fever, wound redness, or a swelling under the arm. **S**
- Next scheduled visit 1993-10-20: review two weeks after mastectomy and axillary dissection: pathology, wound and arm care, and preparation for chemotherapy. **S**
